Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals, Inc.

Sector: Biological Products Except Diagnostic Substances Region: MA, United States

: | Nasdaq: AEGR

Similar to: ALLENEX AB, Bebra Biogas Holding AG, NPS Pharmaceuticals, Inc.

Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It is engaged in the development and commercialization of innovative, life-altering therapies for patients with debilitating and often fatal rare diseases. The company's lead product, lomitapide, is a small molecule, oral therapy to treat severe lipid disorders for an orphan patient population. The company was founded by David I. Scheer and William H. Lewis on February 4, 2005 and is headquartered in Cambridge, MA.

News & Analysis

You may also be interested in: